Recent reports from the World Health Organization (WHO) have highlighted a worrying trend: hepatitis C is on track to become the leading cause of death among viral diseases worldwide. While hepatitis B has always killed more people, hepatitis C is now on the verge of overtaking it.
According to a WHO report, in 2022 alone, hepatitis B and C combined caused 1.3 million deaths worldwide. The alarming increase in the number of deaths attributed to these viruses highlights the urgent need for action to combat their spread.
Experts caution that without prompt action, hepatitis-related deaths could surpass those from tuberculosis, HIV/AIDS, and malaria combined by 2040, especially hepatitis C, which poses a significant threat due to its bloodborne transmission.
The prevalence of viral hepatitis is increasing in low-income countries, where access to prevention and treatment measures remains limited. However, even in developed countries, the virus is spreading rapidly.
Among the ten countries reporting the highest number of hepatitis cases are Pakistan, Bangladesh, China, Ethiopia, India, Indonesia, Nigeria, the Philippines, Russia and Vietnam. Hepatitis C continues to spread beyond these countries, increasing the disease burden around the world.
Currently, hepatitis C is responsible for 83% of hepatitis-related deaths worldwide, with hepatitis B contributing the remaining 17%. Recognizing the symptoms of hepatitis, including fatigue, jaundice and nausea, is crucial for early diagnosis and treatment.
Although hepatitis B vaccines are available, many countries struggle to provide widespread access. Treatment for hepatitis B and C exists, but accessibility is a challenge for many affected.
Efforts to curb the spread of hepatitis must include better access to vaccination, testing and treatment services. Countries can lower hepatitis burden by addressing causes and improving healthcare to save lives.
